Main Industry
Health Care
Main Product/Service
1. CHOptimax?
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
2. CHO-H01
3. CHO-V08
4. CHO-H02
5. CHO-H03
6. CHO-A04
Founded Year
2013
Unified Business No.
54170142
Status
Active
Number of Employees
20
Total Paid-in
Capital
2,140,105,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2017)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in March 2013, CHO Pharma, Inc. is dedicated to the application of innovative sugar platform technology to the development of new drugs and the treatment and detection of diseases associated with carbohydrates. Our vision is to become a leading biopharmaceutical company in the field of sugar molecular technology, and to develop new drugswith high efficacy and low side effects and accurate early detection methods to provide patients with more quality medical treatment through innovative research and development and professional technology.
